These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genetic Analysis of Severe Polycystic Liver Disease in Japan. Mizuno H; Besse W; Sekine A; Long KT; Kurihara S; Oba Y; Yamanouchi M; Hasegawa E; Suwabe T; Sawa N; Ubara Y; Somlo S; Hoshino J Kidney360; 2024 Aug; 5(8):1106-1115. PubMed ID: 38689396 [TBL] [Abstract][Full Text] [Related]
3. Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease. Schönauer R; Sierks D; Boerrigter M; Jawaid T; Caroff L; Audrezet MP; Friedrich A; Shaw M; Degenhardt J; Forberger M; de Fallois J; Bläker H; Bergmann C; Gödiker J; Schindler P; Schlevogt B; Müller RU; Berg T; Patterson I; Griffiths WJ; Sayer JA; ; Popp B; Torres VE; Hogan MC; Somlo S; Watnick TJ; Nevens F; Besse W; Cornec-Le Gall E; Harris PC; Drenth JPH; Halbritter J Gastroenterology; 2024 May; 166(5):902-914. PubMed ID: 38101549 [TBL] [Abstract][Full Text] [Related]
4. Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease. Porath B; Gainullin VG; Cornec-Le Gall E; Dillinger EK; Heyer CM; Hopp K; Edwards ME; Madsen CD; Mauritz SR; Banks CJ; Baheti S; Reddy B; Herrero JI; Bañales JM; Hogan MC; Tasic V; Watnick TJ; Chapman AB; Vigneau C; Lavainne F; Audrézet MP; Ferec C; Le Meur Y; Torres VE; ; ; Harris PC Am J Hum Genet; 2016 Jun; 98(6):1193-1207. PubMed ID: 27259053 [TBL] [Abstract][Full Text] [Related]
5. Severity in polycystic liver disease is associated with aetiology and female gender: Results of the International PLD Registry. van Aerts RMM; Kievit W; de Jong ME; Ahn C; Bañales JM; Reiterová J; Nevens F; Drenth JPH Liver Int; 2019 Mar; 39(3):575-582. PubMed ID: 30225933 [TBL] [Abstract][Full Text] [Related]
6. Clinical manifestation, epidemiology, genetic basis, potential molecular targets, and current treatment of polycystic liver disease. Mahboobipour AA; Ala M; Safdari Lord J; Yaghoobi A Orphanet J Rare Dis; 2024 Apr; 19(1):175. PubMed ID: 38671465 [TBL] [Abstract][Full Text] [Related]
7. Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease. Chebib FT; Jung Y; Heyer CM; Irazabal MV; Hogan MC; Harris PC; Torres VE; El-Zoghby ZM Nephrol Dial Transplant; 2016 Jun; 31(6):952-60. PubMed ID: 26932689 [TBL] [Abstract][Full Text] [Related]
8. Exome Sequencing of a Clinical Population for Autosomal Dominant Polycystic Kidney Disease. Chang AR; Moore BS; Luo JZ; Sartori G; Fang B; Jacobs S; Abdalla Y; Taher M; Carey DJ; Triffo WJ; Singh G; Mirshahi T JAMA; 2022 Dec; 328(24):2412-2421. PubMed ID: 36573973 [TBL] [Abstract][Full Text] [Related]
9. Factors Associated With the Development and Severity of Polycystic Liver in Patients With Autosomal Dominant Polycystic Kidney Disease. Kim Y; Park HC; Ryu H; Kim YC; Ahn C; Lee KB; Kim YH; Han S; Bae EH; Jeong K; Choi J; Oh KH; Oh YK J Korean Med Sci; 2023 Sep; 38(38):e296. PubMed ID: 37750370 [TBL] [Abstract][Full Text] [Related]
10. Genetic Spectrum of Polycystic Kidney and Liver Diseases and the Resulting Phenotypes. Yang H; Sieben CJ; Schauer RS; Harris PC Adv Kidney Dis Health; 2023 Sep; 30(5):397-406. PubMed ID: 38097330 [TBL] [Abstract][Full Text] [Related]
11. Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management. Cnossen WR; Drenth JP Orphanet J Rare Dis; 2014 May; 9():69. PubMed ID: 24886261 [TBL] [Abstract][Full Text] [Related]
12. Mutation Analysis of Autosomal-Dominant Polycystic Kidney Disease Patients. Suzuki Y; Katayama K; Saiki R; Hirabayashi Y; Murata T; Ishikawa E; Ito M; Dohi K Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833371 [TBL] [Abstract][Full Text] [Related]
13. Expanding the variability of the ADPKD-GANAB clinical phenotype in a family of Italian ancestry. Delbarba E; Econimo L; Dordoni C; Martin E; Mazza C; Savoldi G; Alberici F; Scolari F; Izzi C J Nephrol; 2022 Mar; 35(2):645-652. PubMed ID: 34357571 [TBL] [Abstract][Full Text] [Related]
14. Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease. Masyuk T; Masyuk A; Trussoni C; Howard B; Ding J; Huang B; LaRusso N JHEP Rep; 2021 Oct; 3(5):100345. PubMed ID: 34568801 [TBL] [Abstract][Full Text] [Related]